Test Center

My Recent Searches

  • No Recent Search.

My Tests Viewed

  • No Test Viewed.

Showing search results for "thyroid cancer" 31-40 of 250

  1. PTH, Intact and Calcium

    The assay is useful in making the diagnosis of primary hyperparathyroidism, secondary hyperparathyroidism, and a differential diagnosis of hypercalcemia. The assay helps in distinguishing hypercalcemia cause by either …... More

  2. Metanephrines, Fractionated, LC/MS/MS, 24-Hour Urine

    Test is useful in the evaluation of pheochromocytoma.... More

  3. Metanephrines, Fractionated, Free, LC/MS/MS, Plasma

    Normetanephrine (NM) and metanephrine (MN) are the extra-neuronal catechol-o-methyl transferase (COMT) metabolites of the catecholamines norepinephrine and epinephrine, respectively. Measurement of plasma metanephrines …... More

  4. GIvantage Hereditary Colorectal Cancer Panel

    This targeted panel includes 13 cancer genes related to colon, gastric, and pancreatic cancers and polyposis, among other cancer types. It consists mostly of high-penetrant genes for which NCCN has provided medical …... More

  5. MYvantage Hereditary Comprehensive Cancer Panel

    This panel provides comprehensive analysis of 34 hereditary cancer predisposition genes related to breast, ovarian, colon, skin and other cancer types to guide management. It is intended for use in both male and female …... More

  6. Colorectal Cancer Mutation Panel (KRAS, PIK3CA, BRAF, NRAS)

    This panel detecting tumor-associated somatic mutations in 4 different oncogenes can predict response to EGFR-targeted immunotherapy in patients with metastatic colorectal cancer. Tumors with mutations in KRAS, NRAS, …... More

  7. Bladder Cancer, FISH

    UroVysion FISH, detects aneuploidy of chromosomes 3,7,17 and loss of 9p21 locus. Useful for monitoring bladder cancer and in the initial diagnosis of bladder cancer in patients with hematuria.... More

  8. Lung Cancer (NSCLC), ALK 2p23 Rearrangement, FISH

    Non-small cell lung cancer is the leading cause of cancer death worldwide. Tyrosine kinase inhibitors have been demonstrated to reduce lung cancer cell proliferation. The therapeutic efficacy of inhibiting ALK in tumors…... More

  9. Lung Cancer Mutation Panel (EGFR, KRAS, ALK)

    This panel is comprised of mutational analysis of the EGFR and KRAS genes and assessment for ALK locus rearrangement using an FDA-cleared FISH assay. These are the most common tumor-associated genetic changes that have …... More

  10. HE4, Ovarian Cancer Monitoring

    The percentage increase in HE4 values has been used as an aid in monitoring recurrence or progressive disease in patients with invasive epithelial ovarian cancer. Currently there is no clinically accepted cut-off for …... More

* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.